Publication Date: 2025-02-11
Practice Area: Securities Litigation
Industry: Investments and Investment Advisory | Pharmaceuticals
Court: Court of Chancery
Judge: Chancellor McCormick
Attorneys: For plaintiff: Jon E. Abramczyk, D. McKinley Measley, Elizabeth A. Mullin Stoffer, Jacob M. Perrone, Morris, Nichols, Arsht & Tunnell LLP, Wilmington, DE; Monica K. Loseman, John D.W. Partridge, John Turquet Bravard, Gibson, Dunn & Crutcher LLP, Denver, CO; Mary Beth Maloney, Jonathan D. Fortney, Mark H. Mixon, Jr., Gibson, Dunn, Crutcher, New York, NY for plaintiff.
for defendant: Richard R. Rollo, Travis S. Hunter, John M. O’Toole, Kevin M. Kidwell, Edmond S. Kim, Richards, Layton & Finger, P.A., Wilmington, DE; Brad D. Sorrels, Jessica A. Hartwell, Joshua A. Manning, Wilson Sonsini Goodrich & Rosati P.C., Wilmington, DE for defendant.
Case Number: 2024-1102-KSJM
Company did not require preferred stockholder's approval for reverse stock split as the split did not affect the number of authorized shares or fall within the scope of other corporate actions requiring approval under the terms of the stockholder's class of shares.
1 minute read
